JSPR — Jasper Therapeutics, Inc.

—
Nasdaq · Health Care · Biotechnology · CIK 1788028 ·
Last close
$10.34
Market Cap
$344.06M
52W High
$72.60
52W Low
$9.25
ADV30
22,323
Next earnings
2026-11-16

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 8,000,000 7,000 -14,679,000 -144,455,000 147,416,000 135,349,000 287,663,000
Jun 2026 0 — -9,207,000 -2,760,000 11,802,000 7,314,000 10,389,000
Mar 2026 0 — -10,952,000 -1,174,000 21,184,000 14,144,000 17,784,000
Dec 2025 0 — -15,839,000 -9,101,000 35,779,000 28,692,000 31,628,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-60,333,000
Investing CF
$80,000
Financing CF
$34,211,000
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1.59
As of
2026-11-15

Balance + Analyst (yfinance extras)

Retained Earnings
$-320,604,000
Inventory
—
Receivables
—
ST Investments
—
EBIT TTM
$-55,164,000
Pretax Income TTM
$-31,771,000
Interest Exp TTM
—
Analysts
1

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 0 -83,883,000 -75,801,000 35,779,000 31,628,000 4,151,000 -77,161,000
Dec 2024 0 -76,239,000 -71,269,000 79,899,000 18,225,000 61,674,000 -62,602,000
Dec 2023 0 -68,861,000 -64,465,000 94,892,000 16,452,000 78,440,000 -52,067,000
Dec 2022 0 -51,196,000 -37,685,000 48,361,000 12,372,000 35,989,000 -45,858,000

TTM Snapshot

Revenues TTM
$926,000
NetIncome TTM
$-31,771,000
OpCashFlow TTM
—
Assets (Latest)
$11,802,000
Forward EPS
$-2.56

Peers — same industry

TickerNameMarket CapLastDaily %
SLBT SL Science Holding Ltd $356.14M $0.64 —
CCCC C4 Therapeutics, Inc. $332.23M $2.53 —
XFOR X4 Pharmaceuticals, Inc $315.53M $3.09 —
ALEC Alector, Inc. $381.13M $2.56 —
TECX Tectonic Therapeutic, Inc. $392.55M $20.08 —

News headlines (Yahoo Finance, 1h cache)

Jasper Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Update
2026-11-16 13:00 · Yahoo
Jasper Therapeutics, Inc. Announces Results of the Offer to Purchase Relating to Its Warrants
2026-11-09 13:00 · Yahoo
Jasper Therapeutics Announces 1-for-30 Reverse Stock Split
2026-11-04 13:00 · Yahoo
Jasper Therapeutics Announces Completion of Enrollment in First Cohort of Phase 2 Renal Basket Study Evaluating Vensobafusp Alfa (KP104) in IgA Nephropathy
2026-10-15 12:00 · Yahoo
Jasper Therapeutics Announces Commencement of an Offer to Purchase Outstanding Warrants
2026-10-07 12:00 · Yahoo
Jasper Therapeutics Announces Key Regulatory and Clinical Appointments
2026-09-15 20:05 · Yahoo
Jasper Therapeutics beats Q2 expectations but shares fall after results
2026-08-17 12:30 · Yahoo
Jasper gets a lifeline in merger with immune drugmaker Kira
2026-07-17 11:54 · Yahoo
Evercore ISI Lowers its Price Target on Jasper Therapeutics (JSPR) to $7
2026-04-07 14:29 · Yahoo
Jasper Therapeutics Reports Fourth Quarter and Year-End 2025 Financial Results and Provides Corporate Update
2026-03-30 20:30 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.